Trial offers new hope to children and adults with muscle cancer
Only around one in three patients with rhabdomyosarcoma that returns respond to treatment with the chemotherapy drugs vincristine and irinotecan. This trial will test if adding the chemotherapy drug temozolomide will give better response rates and help more people survive the disease.
Dr Julia Chisholm, who will lead the trial at The Royal Marsden NHS Foundation Trust, said: "Current treatments have had good success in treating rhabdomyosarcoma and over 70 per cent of patients survive the disease. But, we urgently need new drugs to offer patients a better chance of beating the disease if it comes back.
"Studies in the US have suggested that vincristine and irinotecan can be used to treat rhabdomyosarcoma that has returned and we want to see if adding temozolomide helps even more patients. If successful, this trial will form the basis for a new standard treatment across Europe to which new targeted drugs can be added as they're developed."
The drug, temozolomide, works by stopping cancer cells making DNA, ultimately stopping the cancer's ability to grow.
The phase II trial will recruit 80 patients across Europe and will be led in the UK by doctors at The Royal Marsden. The trial will be open to patients at eleven hospitals across the UK and will include children and adults up to the age of 50.
The trial is being co-ordinated by the Cancer Research UK Children's Cancer Trials Team, based at the University of Birmingham.
Rhabdomyosarcoma is a cancer that starts in the muscles and can be diagnosed in both children and adults. The treatments used include surgery, chemotherapy, and radiotherapy depending on the type of rhabdomyosarcoma and how aggressive the cancer is. Each year around 55 children in Britain and 30 adults in England are diagnosed with rhabdomyosarcoma. Survival rates in children are just over 60 per cent but survival rates are worse in adults.
This trial launch coincides with Stand Up To Cancer a partnership between Cancer Research UK and Channel 4 that will unite scientists, celebrities and communities across the country to generate funds, raise awareness and bring forward the day when all cancers are cured.
Kate Law, director of clinical research at Cancer Research UK, said: "Temozolomide was first developed by Cancer Research UK scientists to treat brain tumours over 30 years ago. This trial shows how new uses can be found for drugs originally developed for one type of cancer, helping to treat more people with the disease. By funding trials which would not be possible otherwise, Cancer Research UK aims to help more children beat cancer."
Provided by Cancer Research UK
- Cancer Research UK launches trial of new drug to treat acute childhood leukaemia Jan 27, 2012 | not rated yet | 0
- New approach to drug resistance in aggressive childhood cancer discovered Mar 31, 2011 | not rated yet | 0
- Queen's pioneers prostate cancer breakthrough Sep 19, 2011 | not rated yet | 0
- Adding chemo to radiotherapy halves risk of deadly bladder cancer returning Apr 23, 2012 | not rated yet | 0
- Scientist leads successful drug trial for childhood leukaemia Dec 21, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
6 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
Cancer 47 minutes ago | 5 / 5 (1) | 0
For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...
Cancer 1 hour ago | 5 / 5 (1) | 0 |
More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.
Cancer 1 hour ago | 5 / 5 (1) | 0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...
Cancer 2 hours ago | 3.5 / 5 (2) | 0 |
(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.
Cancer 16 hours ago | not rated yet | 0
(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...
57 minutes ago | not rated yet | 0 |
(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...
37 minutes ago | not rated yet | 0 |
Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.
15 minutes ago | 5 / 5 (1) | 0 |
Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.
12 minutes ago | not rated yet | 0 |
Parents naturally are concerned for their children's safety, particularly when there is news of a child abduction that happens close to home. Finding the balance between emotions and the "teachable moment" as parents talk ...
1 hour ago | not rated yet | 0
New techniques in imaging of brain activity developed by Jean Gotman, from McGill University's Montreal Neurological Institute, and his colleagues lead to improved treatment of patients suffering from epilepsy. The combination ...
12 minutes ago | not rated yet | 0